Neuro-fuzzy technology as a predictor of parathyroid hormone level in hemodialysis patients

Tohoku Journal of Experimental Medicine

Volumn 211, Issue 1, 2007, Pages 81-87

  Chen, Chiou An ^a,f   Li, Yu Chuan ^b   Lin, Yuh Feng ^a   Yu, Fu Chiu ^a   Huang, Wei Hsin ^c   Chiu, Jainn Shiun ^d,e  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Taitung Hospital   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Fuzzy logic; Hemodialysis; Neural network; Parathyroid hormone

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; VITAMIN D;

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FORECASTING; FUZZY SYSTEM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEURO FUZZY INFERENCE SYSTEM; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PRESCRIPTION; RADIOIMMUNOASSAY; RENAL OSTEODYSTROPHY;

AGED; ALGORITHMS; ALKALINE PHOSPHATASE; BLOOD CHEMICAL ANALYSIS; CALCIUM; FEMALE; FUZZY LOGIC; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PARATHYROID HORMONE; PHOSPHORUS; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 33846104479     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.211.81     Document Type: Article

References (22)

1. Avram, M.M., Sreedhara, R., Avram, D.K., Muchnick, R.A. & Fein, P. (1996) Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia. Am. J. Kidney Dis., 28, 924-930.
2. Bates, D.W., Kuperman, G.J., Wang, S., Gandhi, T., Kittler, A., Volk, L., Spurr, C., Khorasani, R., Tanasijevic, M. & Middleton, B. (2003) Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J. Am. Med. Inform. Assoc., 10, 523-530.
3. Block, G.A., Klassen, P.S., Lazarus, J.M., Ofsthun, N., Lowrie, E.G. & Chertow, G.M. (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J. Am. Soc. Nephrol., 15, 2208-2218.
4. Chiu, J.S., Chong, C.F., Lin, Y.F., Wu, C.C., Wang, Y.F. & Li, Y.C. (2005) Applying an artificial neural network to predict total body water in hemodialysis patients. Am. J. Nephrol., 25, 507-513.
5. Cunningham, J. (2004) Achieving therapeutic targets in the treatment of secondary hyperparathyroidism. Nephrol. Dial. Transplant., 19, Suppl. 5, V9-V14.
6. Elder, G. (2002) Pathophysiology and recent advances in the management of renal osteodystrophy. J. Bone Miner. Res., 17, 2094-2105.
7. Ferreira, M.A. (2000) Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. Nephrol. Dial. Transplant., 15, Suppl. 5, 8-14.
8. Ferreira, A. & Drueke, T.B. (2000) Biological markers in the diagnosis of the different forms of renal osteodystrophy. Am. J. Med. Sci., 320, 85-89.
9. Hanai, T. & Honda, H. (2004) Application of knowledge information processing methods to biochemical engineering, biomedical and bioinformatics fields. Adv. Biochem. Eng. Biotechnol., 91, 51-73.
10. Hardalac, F., Ozan, A.T., Barisci, N., Ergun, U., Serhatlioglu, S. & Guler, I. (2004) The examination of the effects of obesity on a number of arteries and body mass index by using expert systems. J. Med. Syst., 28, 129-142.
11. Heaf, J.G. & Lokkegard, H. (1998) Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age. J. Nephrol., 11, 203-210.
12. Levin, N.W. & Hoenich, N.A. (2001) Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr. Opin. Nephrol. Hypertens., 10, 563-568.
13. Marshall, M.R., Song, Q., Ma, T.M., MacDonell, S.G. & Kasabov, N.K. (2005) Evolving connectionist system versus algebraic formulas for prediction of renal function from serum creatinine. Kidney Int., 67, 1944-1954.
14. Martin, K.J., Olgaard, K., Coburn, J.W., Coen, G.M., Fukagawa, M., Langman, C., Malluche, H.H., McCarthy, J.T., Massry, S.G., Mehls, O., Salusky, I.B., Silver, J.M., Smogorzewski, M.T, Slatopolsky, E.M. & McCann, L. (2004) Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am. J. Kidney Dis., 43, 558-565.
15. Mehrotra, R., Supasyndh, O., Berman, N., Kaysen, G., Hurst, L., Leonardi, M., Das, D. & Kopple, J.D. (2004) Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake. J. Ren. Nutr., 14, 134-142.
16. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis., 42, S1-201.
17. Oates, J.C., Varghese, S., Bland, A.M., Taylor, T.P., Self, S.E., Stanislaus, R., Almeida, J.S. & Arthur, J.M. (2005) Prediction of urinary protein markers in lupus nephritis. Kidney Int., 68, 2588-2592.
18. Passing, H. & Bablok, W. (1983) A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J. Clin. Chem. Clin. Biochem., 21, 709-720.
19. Payne, R.B., Little, A.J., Williams, R.B. & Milner, J.R. (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Br. Med. J., 4, 643-646.
20. Rae, S.A., Wang, W.J. & Partridge, D. (1999) Artificial neural networks: a potential role in osteoporosis. J.R. Soc. Med., 92, 119-122.
21. Ramesh, A.N., Kambhampati, C., Monson, J.R. & Drew, P.J. (2004) Artificial intelligence in medicine. Ann. R. Coll. Surg. Engl., 86, 334-338.
22. Roe, S. & Cassidy, M.J. (2000) Diagnosis and monitoring of renal osteodystrophy. Curr. Opin. Nephrol. Hypertens., 9, 675-681.